COMPASS THERAPEUTICS INC (CMPX) Stock Analyst Ratings
USA - NASDAQ:CMPX - US20454B1044 - Common Stock
4.23 USD
+0.23 (+5.75%)
4.19 USD
-0.04 (-0.95%)
ChartMill assigns a Buy % Consensus number of 88% to CMPX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 13.17. This target is 211.28% above the current price.
CMPX was analyzed by 17 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about CMPX.
In the previous month the buy percentage consensus was at a similar level.
CMPX was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-05 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-10-06 | LifeSci Capital | Initiate | Outperform |
| 2025-08-12 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-12 | Guggenheim | Maintains | Buy -> Buy |
| 2025-07-01 | Raymond James | Reiterate | Outperform |
| 2025-05-09 | Guggenheim | Maintains | Buy -> Buy |
| 2025-04-28 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-04-22 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-04-21 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-04-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-04 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-04-02 | Leerink Partners | Upgrade | Market Perform -> Outperform |
| 2025-04-02 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-04-01 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-02-27 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-02-25 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-02-24 | Guggenheim | Initiate | Buy |
| 2025-02-19 | Piper Sandler | Initiate | Overweight |
| 2025-02-10 | Jefferies | Maintains | Buy -> Buy |
| 2025-01-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-08 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-01-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-12-23 | D. Boral Capital | Initiate | Buy |
| 2024-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-16 | Ladenburg Thalmann | Upgrade | Neutral -> Buy |
| 2024-08-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-07 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-08-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
COMPASS THERAPEUTICS INC / CMPX FAQ
Can you provide the average price target for COMPASS THERAPEUTICS INC stock?
17 analysts have analysed CMPX and the average price target is 13.17 USD. This implies a price increase of 211.28% is expected in the next year compared to the current price of 4.23.
What is the consensus rating for CMPX stock?
The consensus rating for COMPASS THERAPEUTICS INC (CMPX) is 88.2353 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed COMPASS THERAPEUTICS INC (CMPX)?
The number of analysts covering COMPASS THERAPEUTICS INC (CMPX) is 17.